- Home
- MIRM vs YOU Comparison
MIRM vs YOU Comparison
Compare MIRM & YOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- YOU
- Stock Information
- Founded
- MIRM 2018
- YOU 2010
- Country
- MIRM United States
- YOU United States
- Employees
- MIRM N/A
- YOU N/A
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- YOU Computer Software: Prepackaged Software
- Sector
- MIRM Health Care
- YOU Technology
- Exchange
- MIRM Nasdaq
- YOU Nasdaq
- Market Cap
- MIRM 2.5B
- YOU 2.3B
- IPO Year
- MIRM 2019
- YOU 2021
- Fundamental
- Price
- MIRM $51.12
- YOU $29.76
- Analyst Decision
- MIRM Strong Buy
- YOU Strong Buy
- Analyst Count
- MIRM 9
- YOU 4
- Target Price
- MIRM $66.22
- YOU $34.00
- AVG Volume (30 Days)
- MIRM 351.2K
- YOU 1.3M
- Earning Date
- MIRM 08-11-2025
- YOU 08-05-2025
- Dividend Yield
- MIRM N/A
- YOU 2.59%
- EPS Growth
- MIRM N/A
- YOU 182.03
- EPS
- MIRM N/A
- YOU 1.59
- Revenue
- MIRM $379,251,000.00
- YOU $802,807,000.00
- Revenue This Year
- MIRM $36.76
- YOU $14.81
- Revenue Next Year
- MIRM $17.48
- YOU $10.46
- P/E Ratio
- MIRM N/A
- YOU $18.67
- Revenue Growth
- MIRM 69.31
- YOU 21.59
- 52 Week Low
- MIRM $36.20
- YOU $18.23
- 52 Week High
- MIRM $54.78
- YOU $38.88
- Technical
- Relative Strength Index (RSI)
- MIRM 50.28
- YOU 57.34
- Support Level
- MIRM $50.92
- YOU $29.61
- Resistance Level
- MIRM $52.63
- YOU $30.57
- Average True Range (ATR)
- MIRM 1.49
- YOU 0.87
- MACD
- MIRM -0.35
- YOU -0.12
- Stochastic Oscillator
- MIRM 5.30
- YOU 46.41
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.